The director of the US National Cancer Institute, Norman “Ned” Sharpless has been announced as the acting FDA commissioner, following the shock resignation of incumbent Scott Gottlieb.
GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.
The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.